Two weeks of postsurgical therapy may be enough for high-risk cases of endocarditis caused by Streptococcus viridans or Streptococcus bovis

Clinical Microbiology and Infection

Volumn 18, Issue 3, 2012, Pages 293-299

  Munoz P ^a,b,c   Giannella, M ^a,b   Scoti, F ^d   Predomingo, M ^a   Puga, D ^a   Pinto, A ^a   Roda, J ^a   Marin, M ^a   Bouza, E ^a,b,c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

IE due to Streptococcus spp; IE relapse; Infective endocarditis; Postsurgical antimicrobial therapy; Valve culture

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CIPROFLOXACIN; CLOXACILLIN; GENTAMICIN; RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; EMBOLISM; FEMALE; HEART VALVE REPLACEMENT; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MITRAL ANNULOPLASTY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; REINFECTION; RELAPSE; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS BOVIS; STREPTOCOCCUS VIRIDANS INFECTION; TRICUSPID ANNULOPLASTY; VALVULOPLASTY;

STREPTOCOCCUS; STREPTOCOCCUS BOVIS; STREPTOCOCCUS VIRIDANS;

EID: 84857644923     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03594.x     Document Type: Article

References (18)

1. Hoen B, Alla F, Selton-Suty C et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002; 288: 75-81.
2. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 1995; 74: 324-339.
3. van derMeer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in The Netherlands. II. Antecedent procedures and use of prophylaxis. Arch Intern Med 1992; 152: 1869-1873.
4. Tleyjeh IM, Abdel-Latif A, Rahbi H et al. A systematic review of population-based studies of infective endocarditis. Chest 2007; 132: 1025-1035.
5. Fowler VG Jr, Miro JM, Hoen B et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 24: 3012-3021.
6. Murdoch DR, Corey GR, Hoen B et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 5: 463-473.
7. Habib G, Hoen B, Tornos P et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009; 30: 2369-2413.
8. Morris AJ, Drinkovic D, Pottumarthy S, MacCulloch D, Kerr AR, West T. Bacteriological outcome after valve surgery for active infective endocarditis: implications for duration of treatment after surgery. Clin Infect Dis 2005; 2: 187-194.
9. Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 23: e394-e434.
10. Murray PR, ed. Manual of clinical microbiology, 9th edn. Washington, DC: ASM Press, 2007.
11. Isenberg HD, ed. Clinical microbiology procedures handbook, 2nd edn. Washington, DC: ASM Press, 2004.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Sixteenth informational supplement. Wayne, PA: CLSI, 2006.
13. Marin M, Muñoz P, Sanchez M et al. Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) 2007; 86: 195-202.
14. Muñoz P, Bouza E, Marin M et al. Heart valves should not be routinely cultured. J Clin Microbiol 2008; 46: 2897-2901.
15. Cuevas O, Cercenado E, Bouza E et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Spain: a multicentre prevalence study (2002). Clin Microbiol Infect 2007; 13: 250-256.
16. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
17. Altmann DG, ed. Practical statistics for medical research. London: Chapman & Hall/CRC, 1991.
18. Campbell WN, Tsai W, Mispireta LA. Evaluation of the practice of routine culturing of native valves during valve replacement surgery. Ann Thorac Surg 2000; 69: 548-550.